Thymic epithelial tumor: Clinical Trials

1 trial for Thymic epithelial tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1
Phase 31Not yet recruiting 1

Follow Thymic epithelial tumor: new trials by email Literature Review of Thymic epithelial tumor trials Research Report on Thymic epithelial tumor

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors
Cyclophosphamide, Doxorubicin, and Cisplatin (CAP), nab-Paclitaxel and Carboplatin - Thymoma and Thymic Carcinoma
Phase 2 / Phase 3Not yet recruitingShanghai General Hospital, Shanghai Jiao Tong University School of Medicine1162026-03-012026-03-11

Narrower conditions

Mediastinal Neoplasms (1)  ·  Thymoma (1)

Broader conditions

Hemic and Lymphatic Diseases (1)  ·  Lymphatic Diseases (1)  ·  Mediastinal Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Complex and Mixed (1)  ·  Respiratory Tract Diseases (1)  ·  Thoracic Diseases (1)  ·  Thoracic Neoplasms (1)  ·  Thymus Neoplasms (1)

Interventions

130-nm albumin-bound paclitaxel (1)  ·  Carboplatin (1)  ·  Cisplatin (1)  ·  Cyclophosphamide (1)  ·  Doxorubicin (1)

Sponsors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)

Countries

China (1)

Top investigators

Fan Jiang, MD, PhD (1)